# STRATEGY for Left Main Coronary Bifurcation Lesion II

Study · id `cardio:ct-nct01798433` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01798433](<https://clinicaltrials.gov/study/NCT01798433>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01798433

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

## Technical summary

Registry record NCT01798433. Randomized; no masking; primary purpose treatment. Start 2013-03-18 (actual); primary completion 2018-07-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (enrolled count; ClinicalTrials.gov record NCT01798433, source copy `cardio:ctgov-nct01798433-2019-01-02`, retrieved 2026-10-26)
- Started: 2013-03-18 (actual) (ClinicalTrials.gov record NCT01798433, source copy `cardio:ctgov-nct01798433-2019-01-02`, retrieved 2026-10-26)
- Primary completion: 2018-07-31 (actual) (ClinicalTrials.gov record NCT01798433, source copy `cardio:ctgov-nct01798433-2019-01-02`, retrieved 2026-10-26)
- Completion: 2018-07-31 (actual) (ClinicalTrials.gov record NCT01798433, source copy `cardio:ctgov-nct01798433-2019-01-02`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT01798433, source copy `cardio:ctgov-nct01798433-2019-01-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01798433-2019-01-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: STRATEGY for Left Main Coronary Bifurcation Lesion II
- Acronym: STRATEGY-II
- Condition: Coronary Artery Disease
- Intervention (Device): One stent technique alone
- Intervention (Device): One stent technique + Elective FKB
- Intervention (Procedure): Provisional approach
- Intervention (Device): Elective 2-stent
- Lead sponsor: Samsung Medical Center
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Samsung Medical Center (`cardio:org-samsung-medical-center`)

## Provenance

Content hash: 5ac2643380f483dae72e841313c79d553cf0a423679c03f174eea8c810cea0f5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
